Company / Current Assets
Centessa Pharmaceuticals plc Current Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$367.9M
FY2025
5-year range
$315.1M / $628.8M
FY2021-FY2025
Trend
-31.4%
vs FY2024
Sector context
#141 of 213
Health Care
What the data says
At $368M, Centessa Pharmaceuticals plc's current assets ranks #141 of 213 in the Health Care sector. Current Assets has fluctuated over the past 6 years, ranging from $11M in FY2020 to $629M in FY2021.
Based on SEC 10-K filings.
$368M in FY2025 with a 5-year CAGR of +101.2%.
Improved from $315M to $368M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -5.6%
- 5-Year CAGR
- +101.2%
- 10-Year CAGR
- -
Sector benchmark
#141 of 213 in Health CareTop 66% of 213This company $367.9M Sector average $2.5B
▼
-85.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +101.2%, indicating consistent growth.
- In FY2025, current assets decreased 31.4% year-over-year.
- Ranks #141 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $367.9M | -31.4% |
| FY2024 | $536.4M | +70.2% |
| FY2023 | $315.1M | -28.0% |
| FY2022 | $437.7M | -30.4% |
| FY2021 | $628.8M | +5531.7% |
| FY2020 | $11.2M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026